PIPERAZINE ALS ANTIMALARIAMITTEL

Patent europeic · EP2521715 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2521715
Numer da la dumonda
EP11702702
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
04-01-2011
Publitgà
14-11-2012
Concedì
25-06-2014
Stritgà
24-08-2024
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 213/56 (2006.01)
C07D 213/64 (2006.01)
C07D 295/185 (2006.01)
A61K 31/495 (2006.01)
A61K 31/496 (2006.01)
A61P 33/02 (2006.01)
A61P 33/06 (2006.01)
Prioritad
WO PCT/IB2010/052045 10.05.2010
WO PCT/IB2010/050022 05.01.2010
Dumonda PCT
PCT/IB2011/050009 04.01.2011
Publicaziun PCT
WO2011/083413 14.07.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-08-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.08.2024

  2. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  3. 14-09-2017

    Transferì

    Owner
    Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil → Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil

    Published in Swissreg on 14.09.2017

  4. 25-06-2014

    Concedì

    Published in Swissreg on 25.06.2014

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.